Reticular Subepithelial Corneal Deposits in a Patient Receiving Niraparib Therapy

Niraparib therapy may be associated with corneal drug deposition. The pattern of subepithelial drug deposition seen in this case is distinct to other commonly reported drug deposits.

Authors

Institutions

Publication Details

Journal
Cornea
Published
2025-09-29
DOI
https://doi.org/10.1097/ico.0000000000004001
Citations
1
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Reticular Subepithelial Corneal Deposits in a Patient Receiving Niraparib Therapy

David Lockington, Sahib Y. Tuteja
1 citations
Cornea
PARP inhibition in cancer therapy
1.05
article

Reticular Subepithelial Corneal Deposits in a Patient Receiving Niraparib Therapy

David Lockington, Sahib Y. Tuteja
article en
1 citations

Abstract

Niraparib therapy may be associated with corneal drug deposition. The pattern of subepithelial drug deposition seen in this case is distinct to other commonly reported drug deposits.

CorneaVol. 45(4)
Gartnavel General Hospital (GB)
Openalex Percentile: Top 17%
PARP inhibition in cancer therapy
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Reticular Subepithelial Corneal Deposits in a Patient Receiving Niraparib Therapy — David Lockington, Sahib Y. Tuteja · Cornea (2025) | TGRS Research Map | TGRS